News

TS DOST 2025 Phase 3 Seat Allotment: Steps to check the result. Step 1: Visit dost.cgg.gov.in, the official TS DOST website. Step 2: On the homepage, select the "Candidate's Login" tab.
A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but demonstrated fast-acting healing of the ocular surface, according to a ...
HOUSTON, Texas (KTRK) -- Three Houston-area women are accused of defrauding the US government out of more than $80 million in federal Medicaid and Medicare reimbursement funds.
Novo Nordisk (NYSE:NVO) engages in the research & development, manufacture, and distribution of pharmaceutical products internationally. It has 2 segments: Diabetes & Obesity Care and Rare Disease.
Wednesday, June 25, 2025 3:25PM Three Houston-area women are accused of defrauding the US government out of more than $80 million in federal Medicaid and Medicare reimbursement funds.
By Haley Britzky, CNN (CNN) — The US Departments of the Navy and Air Force are expected to announce the establishment of two additional military zones along the US southern border this week ...
At 6-foot-7 and just 22 years old, Kuminga averaged 15.3 points, ... finishing an impressive 71.6% in the restricted area. If Sacramento were to land him, ...
The NCAA announced on June 25 that its Division I Council approved a change to the maximum number of games allowed in the college basketball regular season.
A year ago in May, unemployment was 3.7%. In May 2024, the labor force included 232,246 people, state figures show. But last month, it was notably larger at 235,320 people.
The 6-foot-8, 22-year-old averaged 15.3 points, ... He may not be the best shooter, but he excels at getting to and finishing at the rim, shooting 71.6% in the restricted area last season.
Once-restricted Shipki-La, a motorable mountain pass in the Kinnaur district, is seeing a surge with nearly 2,000 domestic tourists, including women and children, visiting the site since June 10 ...
Its rival Moderna said earlier this month, however, that it has already fully enrolled a 6,000-subject phase 3 study of its quadrivalent vaccine candidate mRNA-1010 in the southern hemisphere, ...